Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

37.06
+1.123.13%
Volume:414
Turnover:15.19K
Market Cap:2.78M
PE:- -
High:37.09
Open:36.11
Low:36.11
Close:35.93
52wk High:45.88
52wk Low:25.71
Shares:75.00K
Float Shares:75.00K
Volume Ratio:0.79
T/O Rate:0.55%
Dividend:0.76
Dividend Rate:2.06%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Stocks to Watch: Micron, Alphabet, Sanofi, Nu Holdings

Dow Jones
·
Oct 01

Sanofi’s Regeneron Fix Requires Extra Shot of M&A

Reuters
·
Oct 01

Sanofi CEO Takes First Step Toward Addressing Long-Term Outlook

Dow Jones
·
Oct 01

Sanofi to Get Pipeline Boost from Expanded Regeneron Alliance

Dow Jones
·
Oct 01

Sanofi, Regeneron Expand Tie-up with $8 Billion Drug-Development Deal, Settle Legal Dispute

Reuters
·
Oct 01

Regeneron, Sanofi Expand Antibody Alliance with USD 1 Billion Upfront Payment

Reuters
·
Oct 01

Sanofi, Regeneron Expand Antibody Alliance in Long-Acting Immunology Programs for USD 1 Billion Upfront

Reuters
·
Oct 01

Sanofi - Companies to Equally Share Development and Commercialization Costs, as Well as Any Future Profits

THOMSON REUTERS
·
Oct 01

Sanofi - and Regeneron Settle Prior Collaboration-Related Litigation

THOMSON REUTERS
·
Oct 01

Sanofi - Regeneron May Include Sanofi's Lunsekimig Therapy After Phase 3 Studies

THOMSON REUTERS
·
Oct 01

Sanofi - Regeneron to Receive $1 Bln Upfront with Potential for up to an Additional $7 Bln in Future Milestone Payments

THOMSON REUTERS
·
Oct 01

Arovella Nears First Patient Dosing in Pivotal ALA-101 Cell Therapy Trial

TIPRANKS
·
Oct 01

The Next Frontier for Obesity Drugs Isn't How Much Weight You Lose, but What Kind

Dow Jones
·
Oct 01

Paramount Names Kreiz as Co-CEO as Warner Bros. Deal Nears Completion

Deep News
·
Oct 01

Regeneron Drug Halves Muscle Loss in Combination with Novo's Semaglutide in Trial

Reuters
·
Oct 01

Gilead Sciences Inc. Stock Underperforms Wednesday When Compared to Competitors

Dow Jones
·
Oct 01

Moderna Inc. Stock Sheds 5.4%, Underperforms Peers

Dow Jones
·
Oct 01

Regeneron Links 2026 CEO, CSO PSU Awards to FDA Filings, Approvals and New-Product Revenue Targets Through 2035

Reuters
·
Oct 01

Gilead put volume heavy and directionally bearish

TIPRANKS
·
Oct 01

Regeneron’s ALN-F1202 Safety Trial Marks a Quiet but Important Pipeline Milestone

TIPRANKS
·
Oct 01